Ken Griffin
TGTX icon

Ken Griffin’s TG Therapeutics TGTX Stock Holding History

Ken Griffin’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63.9M Buy
1,922,889
+911,852
+90% +$27.2M 0.01% 1140
2025
Q4 		$30.1M Buy
1,011,037
+18,334
+2% +$599K ﹤0.01% 1899
2025
Q3 		$35.9M Sell
992,703
-51,765
-5% -$1.71M 0.01% 1696
2025
Q2 		$37.6M Buy
1,044,468
+398,591
+62% +$14.8M 0.01% 1472
2025
Q1 		$25.5M Buy
645,877
+131,917
+26% +$4.44M ﹤0.01% 1765
2024
Q4 		$15.5M Buy
513,960
+388,826
+311% +$11.2M ﹤0.01% 2444
2024
Q3 		$2.93M Sell
125,134
-1,734,658
-93% -$37.9M ﹤0.01% 4832
2024
Q2 		$33.1M Sell
1,859,792
-18,541
-1% -$296K 0.01% 1513
2024
Q1 		$28.6M Buy
1,878,333
+1,413,871
+304% +$22.5M 0.01% 1712
2023
Q4 		$7.93M Buy
464,462
+80,151
+21% +$932K ﹤0.01% 3146
2023
Q3 		$3.21M Buy
384,311
+204,942
+114% +$2.86M ﹤0.01% 4359
2023
Q2 		$4.46M Sell
179,369
-888,876
-83% -$23M ﹤0.01% 3825
2023
Q1 		$16.1M Buy
1,068,245
+717,145
+204% +$10.9M ﹤0.01% 2181
2022
Q4 		$4.15M Sell
351,100
-1,212,275
-78% -$8.8M ﹤0.01% 4177
2022
Q3 		$9.26M Sell
1,563,375
-154,069
-9% -$1.01M ﹤0.01% 2882
2022
Q2 		$7.3M Buy
1,717,444
+640,516
+59% +$4M ﹤0.01% 3127
2022
Q1 		$10.2M Buy
1,076,928
+1,033,607
+2,386% +$12M ﹤0.01% 2912
2021
Q4 		$824K Sell
43,321
-116,012
-73% -$3.01M ﹤0.01% 8416
2021
Q3 		$5.3M Buy
159,333
+74,608
+88% +$2.31M ﹤0.01% 4184
2021
Q2 		$3.29M Sell
84,725
-2,312
-3% -$90.8K ﹤0.01% 5377
2021
Q1 		$4.2M Sell
87,037
-591,729
-87% -$28.4M ﹤0.01% 4660
2020
Q4 		$35.3M Buy
678,766
+174,554
+35% +$5.9M 0.01% 1246
2020
Q3 		$13.5M Buy
504,212
+531
+0.1% +$12.2K ﹤0.01% 1947
2020
Q2 		$9.81M Sell
503,681
-1,677,036
-77% -$27M ﹤0.01% 2240
2020
Q1 		$21.5M Buy
2,180,717
+1,196,536
+122% +$15.1M 0.01% 1186
2019
Q4 		$10.9M Buy
984,181
+520,890
+112% +$3.96M ﹤0.01% 2100
2019
Q3 		$2.6M Buy
463,291
+354,967
+328% +$2.47M ﹤0.01% 4071
2019
Q2 		$937K Buy
108,324
+70,349
+185% +$532K ﹤0.01% 5793
2019
Q1 		$305K Sell
37,975
-149,713
-80% -$809K ﹤0.01% 7590
2018
Q4 		$770K Sell
187,688
-220,158
-54% -$1.09M ﹤0.01% 5715
2018
Q3 		$2.28M Buy
407,846
+193,697
+90% +$2.21M ﹤0.01% 4192
2018
Q2 		$2.82M Buy
214,149
+24,234
+13% +$333K ﹤0.01% 3578
2018
Q1 		$2.7M Buy
189,915
+85,669
+82% +$1.09M ﹤0.01% 3289
2017
Q4 		$855K Sell
104,246
-6,819
-6% -$59.6K ﹤0.01% 4882
2017
Q3 		$1.32M Buy
111,065
+44,364
+67% +$505K ﹤0.01% 3935
2017
Q2 		$670K Sell
66,701
-87,737
-57% -$982K ﹤0.01% 4703
2017
Q1 		$1.8M Buy
+154,438
New +$1.11M ﹤0.01% 3182
2016
Q4 		– Sell
-40,112
Closed -$235K – 7830
2016
Q3 		$311K Sell
40,112
-3,889
-9% -$25K ﹤0.01% 5623
2016
Q2 		$267K Buy
+44,001
New +$358K ﹤0.01% 5396
2016
Q1 		– Sell
-31,383
Closed -$275K – 7943
2015
Q4 		$374K Buy
31,383
+9,757
+45% +$123K ﹤0.01% 4881
2015
Q3 		$218K Sell
21,626
-14,681
-40% -$219K ﹤0.01% 6029
2015
Q2 		$602K Sell
36,307
-27,390
-43% -$434K ﹤0.01% 4687
2015
Q1 		$986K Buy
63,697
+47,863
+302% +$725K ﹤0.01% 3938
2014
Q4 		$251K Sell
15,834
-10,285
-39% -$134K ﹤0.01% 5684
2014
Q3 		$279K Buy
26,119
+20,642
+377% +$191K ﹤0.01% 5348
2014
Q2 		$51K Sell
5,477
-32,129
-85% -$205K ﹤0.01% 6725
2014
Q1 		$259K Buy
37,606
+29,825
+383% +$177K ﹤0.01% 5202
2013
Q4 		$30K Buy
+7,781
New +$31.4K ﹤0.01% 6278

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ken Griffin's TGTX Position: Q1 2026 in Review

Ken Griffin increased its TG Therapeutics (TGTX) stake by 90% in Q1 2026, buying an estimated $27.2M and bringing the position to 1,922,889 shares worth $63.9M. The position accounts for 0.01% of the portfolio, ranked #1140.

Ken Griffin first reported a position in TGTX in Q4 2013 and has held it in 48 quarters since. 364 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

  • Ken Griffin held 1,922,889 shares of TG Therapeutics worth $63.9M as of Q1 2026.
  • Ken Griffin bought 911,852 TG Therapeutics shares in Q1 2026, an estimated $27.2M.
  • TG Therapeutics made up 0.01% of Ken Griffin's portfolio in Q1 2026, its #1140 holding.
  • Ken Griffin first reported a position in TG Therapeutics in Q4 2013 and has held it in 48 quarters since.
  • 364 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.